Get email alerts when ARTV insiders make a move — free, no credit card

ARTV Insider Trading & Form 4 Activity

Artiva Biotherapeutics, Inc.
Last filing: Oct 7, 2026·17 days ago
BEARISH · LAST 90 DAYS
20%
buyers
$456K
2 buys
$1.5M
8 sells
-$1.0M
net selling
5
insiders
Tracking ARTV insiders takes 3 seconds. Get free alerts →
ACTIVE SELLING CLUSTER

4 insiders sold a combined $912K of ARTV on Sep 3, 2026.

Banerjee Subhashis, Bush Jennifer, Horan Christopher, Aslan Fred

Don't miss the next ARTV cluster. Tracenotes detected this one — get the next alert free.

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Aslan Fred
Chief Executive Officer
—
$1.5M
-$1.5M
Ra Capital Management, L.p.
Director
$456K
—
$456K
Horan Christopher
Chief Tech Operations Officer
—
$186K
-$186K
Bush Jennifer
COO, CLO, Compliance Officer
—
$151K
-$151K
Banerjee Subhashis
Chief Medical Officer
—
$124K
-$124K
Miralles Gines Diego
President & Head of R&D
—
—
$0

Recent transactions

Every Form 4 transaction for ARTV, newest first.

SELL10b5-1
Aslan Fred · Chief Executive Officer
Tx Oct 6·Filed Oct 7·EDGAR ↗
23,463 sh @ $7.20
$169K
SELL
Aslan Fred · Chief Executive Officer
Tx Oct 5·Filed Oct 6·EDGAR ↗
61,696 sh @ $6.84
$422K
SELL
Bush Jennifer · COO, CLO, Compliance Officer
Tx Oct 5·Filed Oct 6·EDGAR ↗
8,370 sh @ $6.84
$57K
SELL
Horan Christopher · Chief Tech Operations Officer
Tx Oct 5·Filed Oct 6·EDGAR ↗
10,340 sh @ $6.84
$71K
SELL
Banerjee Subhashis · Chief Medical Officer
Tx Oct 5·Filed Oct 6·EDGAR ↗
1,099 sh @ $6.84
$8K
AWARD
Aslan Fred · Chief Executive Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
110,000 sh
—
AWARD
Aslan Fred · Chief Executive Officer
Tx Sep 10·Filed Sep 14·EDGAR ↗
45,000 sh
—
AWARD
Horan Christopher · Chief Tech Operations Officer
Tx Sep 9·Filed Sep 11·EDGAR ↗
40,000 sh
—
AWARD
Banerjee Subhashis · Chief Medical Officer
Tx Sep 9·Filed Sep 11·EDGAR ↗
30,000 sh
—
AWARD
Miralles Gines Diego · President & Head of R&D
Tx Sep 9·Filed Sep 11·EDGAR ↗
45,000 sh
—
AWARD
Bush Jennifer · COO, CLO, Compliance Officer
Tx Sep 9·Filed Sep 11·EDGAR ↗
45,000 sh
—
SELL10b5-1
Aslan Fred · Chief Executive Officer
Tx Sep 8·Filed Sep 9·EDGAR ↗
23,429 sh @ $10.92
$256K
SELL
Banerjee Subhashis · Chief Medical Officer
Tx Sep 3·Filed Sep 4·EDGAR ↗
1,100 sh @ $11.16
$12K
SELL
Bush Jennifer · COO, CLO, Compliance Officer
Tx Sep 3·Filed Sep 4·EDGAR ↗
8,391 sh @ $11.16
$94K
SELL
Horan Christopher · Chief Tech Operations Officer
Tx Sep 3·Filed Sep 4·EDGAR ↗
10,366 sh @ $11.16
$116K
SELL
Aslan Fred · Chief Executive Officer
Tx Sep 3·Filed Sep 4·EDGAR ↗
61,888 sh @ $11.16
$690K
EXERCISE10b5-1
Banerjee Subhashis · Chief Medical Officer
Tx Aug 27·Filed Aug 31·EDGAR ↗
5,306 sh @ $1.92
$10K
SELL10b5-1
Banerjee Subhashis · Chief Medical Officer
Tx Aug 27·Filed Aug 31·EDGAR ↗
8,222 sh @ $12.01
$99K
EXERCISE10b5-1
Banerjee Subhashis · Chief Medical Officer
Tx Aug 18·Filed Aug 19·EDGAR ↗
429 sh @ $1.92
$824
SELL10b5-1
Banerjee Subhashis · Chief Medical Officer
Tx Aug 18·Filed Aug 19·EDGAR ↗
429 sh @ $12.00
$5K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 31·Filed Jul 31·EDGAR ↗
24,944 sh @ $9.93
$248K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 29·Filed Jul 31·EDGAR ↗
20,824 sh @ $9.99
$208K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 24·Filed Jul 28·EDGAR ↗
41,319 sh @ $9.99
$413K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 23·Filed Jul 23·EDGAR ↗
59,880 sh @ $9.96
$596K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 22·Filed Jul 23·EDGAR ↗
84,124 sh @ $9.93
$835K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 21·Filed Jul 23·EDGAR ↗
120,582 sh @ $9.55
$1.2M
BUY
Ra Capital Management, L.p. · Director
Tx Jul 13·Filed Jul 23·EDGAR ↗
6,522 sh @ $8.94
$58K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 17·Filed Jul 20·EDGAR ↗
7,882 sh @ $8.95
$71K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 16·Filed Jul 20·EDGAR ↗
152,472 sh @ $8.93
$1.4M
BUY
Ra Capital Management, L.p. · Director
Tx Jul 13·Filed Jul 14·EDGAR ↗
6,552 sh @ $8.94
$59K
BUY
Ra Capital Management, L.p. · Director
Tx Jul 10·Filed Jul 14·EDGAR ↗
15,102 sh @ $8.97
$135K
BUY
Ra Capital Management, L.p. · Director
Tx Jun 26·Filed Jun 29·EDGAR ↗
1,876 sh @ $8.98
$17K
BUY
Ra Capital Management, L.p. · Director
Tx Jun 25·Filed Jun 29·EDGAR ↗
31,000 sh @ $8.88
$275K
BUY
Ra Capital Management, L.p. · Director
Tx Jun 16·Filed Jun 16·EDGAR ↗
124,893 sh @ $8.89
$1.1M
BUY
Ra Capital Management, L.p. · Director
Tx Jun 15·Filed Jun 16·EDGAR ↗
15,414 sh @ $8.99
$139K
BUY
Ra Capital Management, L.p. · Director
Tx Jun 12·Filed Jun 16·EDGAR ↗
391,019 sh @ $8.57
$3.4M
BUY
Ra Capital Management, L.p. · Director
Tx Jun 11·Filed Jun 11·EDGAR ↗
548,580 sh @ $7.91
$4.3M
BUY
Ra Capital Management, L.p. · Director
Tx Jun 10·Filed Jun 11·EDGAR ↗
103 sh @ $7.00
$721
BUY
Ra Capital Management, L.p. · Director
Tx Jun 9·Filed Jun 11·EDGAR ↗
479,039 sh @ $6.91
$3.3M
BUY
Gc Corp. · Insider
Tx May 11·Filed May 28·EDGAR ↗
347,222 sh @ $11.52
$4.0M
BUY
Gc Corp. · Insider
Tx May 11·Filed May 28·EDGAR ↗
1,085,069 sh @ $11.52
$12.5M
SELL
Banerjee Subhashis · Chief Medical Officer
Tx May 19·Filed May 19·EDGAR ↗
7,037 sh @ $9.01
$63K
SELL
Aslan Fred · Chief Executive Officer
Tx May 19·Filed May 19·EDGAR ↗
27,116 sh @ $9.01
$244K
SELL
Bush Jennifer · COO, CLO, Compliance Officer
Tx May 19·Filed May 19·EDGAR ↗
8,790 sh @ $9.01
$79K
SELL
Raymon Heather · SVP, Research and Development
Tx May 19·Filed May 19·EDGAR ↗
3,095 sh @ $9.01
$28K
SELL
Horan Christopher · Chief Tech Operations Officer
Tx May 19·Filed May 19·EDGAR ↗
7,002 sh @ $9.01
$63K
AWARD
Miralles Gines Diego · President & Head of R&D
Tx May 18·Filed May 19·EDGAR ↗
77,500 sh
—
BUY
Ra Capital Management, L.p. · Director
Tx May 11·Filed May 13·EDGAR ↗
6,510,416 sh @ $11.52
$75.0M

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About ARTV insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for ARTV from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying ARTV always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Artiva Biotherapeutics, Inc. (ARTV) when they form.

Where does ARTV insider trading data come from?

Every Form 4 filing for ARTV is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai